Inactivation of insulin-like-growth factors diminished the anabolic effects of pregnancy-associated plasma protein-A (PAPP-A) on bone in mice

Growth Hormone and IGF Research

Volumn 20, Issue 3, 2010, Pages 192-200

  Phang, David ^a   Rehage, Mark ^a   Bonafede, Blake ^a   Hou, Diana ^a   Xing, Weirong ^a,b   Mohan, Subburaman ^a,b   Wergedal, Jon E ^a,b   Qin, Xuezhong ^a,b  

^a LOMA LINDA UNIVERSITY   (United States)

^b LOMA LINDA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

IGF; IGFBP; PAPP A; Transgenic mice

Indexed keywords

PREGNANCY ASSOCIATED PLASMA PROTEIN A; SOMATOMEDIN; SOMATOMEDIN BINDING PROTEIN 4;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE DENSITY; BONE DEVELOPMENT; BONE SIZE; BONE THICKNESS; CALVARIA; CONTROLLED STUDY; DRUG MECHANISM; FEMUR; LONG BONE; MOUSE; MUSCULOSKELETAL SYSTEM PARAMETERS; NONHUMAN; OSSIFICATION; OSTEOMETRY; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DEGRADATION; SKULL BASE; TIBIA; TRANSGENIC MOUSE;

ANIMALS; BONE AND BONES; BONE DEVELOPMENT; CELLS, CULTURED; FEMALE; GENE SILENCING; GENES, TRANSGENIC, SUICIDE; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 4; MALE; METABOLISM; MICE; MICE, INBRED C57BL; MICE, INBRED CBA; PREGNANCY; PREGNANCY-ASSOCIATED PLASMA PROTEIN-A; SOMATOMEDINS;

EID: 77953081721     PISSN: 10966374     EISSN: 15322238     Source Type: Journal    
DOI: 10.1016/j.ghir.2010.01.001     Document Type: Article

References (33)

1. Bale L.K., Conover C.A. Disruption of insulin-like growth factor-II imprinting during embryonic development rescues the dwarf phenotype of mice null for pregnancy-associated plasma protein-A. J. Endocrinol. 2005, 186:325-331.
2. Bayes-Genis A., Schwartz R.S., Lewis D.A., Overgaard M.T., Christiansen M., Oxvig C., Ashai K., Holmes D.R., Conover C.A. Insulin-like growth factor binding protein-4 protease produced by smooth muscle cells increases in the coronary artery after angioplasty. Arterioscler. Thromb. Vasc. Biol. 2001, 21:335-341.
3. Boldt H.B., Conover C.A. Pregnancy-associated plasma protein-A (PAPP-A): a local regulator of IGF bioavailability through cleavage of IGFBPs. Growth Horm. IGF Res. 2007, 17:10-18.
4. Byun D., Mohan S., Yoo M., Sexton C., Baylink D.J., Qin X. Pregnancy-associated plasma protein-A accounts for the insulin-like growth factor (IGF)-binding protein-4 (IGFBP-4) proteolytic activity in human pregnancy serum and enhances the mitogenic activity of IGF by degrading IGFBP-4 in vitro. J. Clin. Endocrinol. Metab. 2001, 86:847-854.
5. Conover C.A., Bale L.K., Overgaard M.T., Johnstone E.W., Laursen U.H., Fuchtbauer E.M., Oxvig C., van Deursen J. Metalloproteinase pregnancy-associated plasma protein A is a critical growth regulatory factor during fetal development. Development 2004, 131:1187-1194.
6. Florini J.R., Ewton D.Z., Coolican S.A. Growth hormone and the insulin-like growth factor system in myogenesis. Endocr. Rev. 1996, 17:481-517.
7. Han V.K., Matsell D.G., Delhanty P.J., Hill D.J., Shimasaki S., Nygard K. IGF-binding protein mRNAs in the human fetus: tissue and cellular distribution of developmental expression. Horm. Res. 1996, 45:160-166.
8. Kumar A., Mohan S., Newton J., Rehage M., Tran K., Baylink D.J., Qin X. Pregnancy-associated plasma protein-A regulates myoblast proliferation and differentiation through an insulin-like growth factor-dependent mechanism. J. Biol. Chem. 2005, 280:37782-37789.
9. Laursen L.S., Overgaard M.T., Soe R., Boldt H.B., Sottrup-Jensen L., Giudice L.C., Conover C.A., Oxvig C. Pregnancy-associated plasma protein-A (PAPP-A) cleaves insulin-like growth factor binding protein (IGFBP)-5 independent of IGF: implications for the mechanism of IGFBP-4 proteolysis by PAPP-A. FEBS Lett. 2001, 504:36-40.
10. Lawrence J.B., Oxvig C., Overgaard M.T., Sottrup-Jensen L., Gleich G.J., Hays L.G., Yates J.R., Conover C.A. The insulin-like growth factor (IGF)-dependent IGF binding protein-4 protease secreted by human fibroblasts is pregnancy-associated plasma protein-A. Proc Natl Acad Sci U S A 1999, 96:3149-3153.
11. Miller B.S., Bronk J.T., Nishiyama T., Yamagiwa H., Srivastava A., Bolander M.E., Conover C.A. Pregnancy associated plasma protein-A is necessary for expeditious fracture healing in mice. J. Endocrinol. 2007, 192:505-513.
12. Miyakoshi N., Qin X., Kasukawa Y., Richman C., Srivastava A.K., Baylink D.J., Mohan S. Systemic administration of insulin-like growth factor (IGF)-binding protein-4 (IGFBP-4) increases bone formation parameters in mice by increasing IGF bioavailability via an IGFBP-4 protease-dependent mechanism. Endocrinology 2001, 142:2641-2648.
13. Miyakoshi N., Richman C., Kasukawa Y., Linkhart T.A., Baylink D.J., Mohan S. Evidence that IGF-binding protein-5 functions as a growth factor. J. Clin. Invest. 2001, 107:73-81.
14. Mohan S., Libanati C., Dony C., Lang K., Srinivasan N., Baylink D.J. Development, validation, and application of a radioimmunoassay for insulin-like growth factor binding protein-5 in human serum and other biological fluids. J. Clin. Endocrinol. Metab. 1995, 80:2638-2645.
15. Monget P., Mazerbourg S., Delpuech T., Maurel M.C., Maniere S., Zapf J., Lalmanach G., Oxvig C., Overgaard M.T. Pregnancy-associated plasma protein-A is involved in insulin-like growth factor binding protein-2 (IGFBP-2) proteolytic degradation in bovine and porcine preovulatory follicles: identification of cleavage site and characterization of IGFBP-2 degradation. Biol. Reprod. 2003, 68:77-86.
16. Ning Y., Schuller A.G., Conover C.A., Pintar J.E. Insulin-like growth factor (IGF) binding protein-4 is both a positive and negative regulator of IGF activity in vivo. Mol. Endocrinol. 2008, 22:1213-1225.
17. Oliver W.T., Rosenberger J., Lopez R., Gomez A., Cummings K.K., Fiorotto M.L. The local expression and abundance of IGF binding proteins in skeletal muscle are regulated by age and gender, but not local IGF-I in vivo. Endocrinology 2005.
18. Overgaard M.T., Oxvig C., Christiansen M., Lawrence J.B., Conover C.A., Gleich G.J., Sottrup-Jensen L., Haaning J. Messenger ribonucleic acid levels of pregnancy-associated plasma protein-A and the proform of eosinophil major basic protein: expression in human reproductive and nonreproductive tissues. Biol. Reprod. 1999, 61:1083-1089.
19. Qin X., Byun D., Strong D.D., Baylink D.J., Mohan S. Studies on the role of human insulin-like growth factor-II (IGF-II)-dependent IGF binding protein (hIGFBP)-4 protease in human osteoblasts using protease-resistant IGFBP-4 analogs. J. Bone Miner. Res. 1999, 14:2079-2088.
20. Qin X., Sexton C., Byun D., Strong D.D., Baylink D.J., Mohan S. Differential regulation of pregnancy associated plasma protein (PAPP)-A during pregnancy in human and mouse. Growth Horm. IGF Res. 2002, 12:359-366.
21. Qin X., Strong D.D., Baylink D.J., Mohan S. Structure-function analysis of the human insulin-like growth factor binding protein-4. J. Biol. Chem. 1998, 273:23509-23516.
22. Qin X., Wergedal J.E., Rehage M., Tran K., Newton J., Lam P., Baylink D.J., Mohan S. Pregnancy-associated plasma protein-A increases osteoblast proliferation in vitro and bone formation in vivo. Endocrinology 2006, 147:5653-5661.
23. Rehage M., Mohan S., Wergedal J.E., Bonafede B., Tran K., Hou D., Phang D., Kumar A., Qin X. Transgenic overexpression of pregnancy-associated plasma protein-a increases the somatic growth and skeletal muscle mass in mice. Endocrinology 2007, 148:6176-6185.
24. Resch Z.T., Simari R.D., Conover C.A. Targeted disruption of the pregnancy-associated plasma protein-A gene is associated with diminished smooth muscle cell response to insulin-like growth factor-I and resistance to neointimal hyperplasia after vascular injury. Endocrinology 2006, 147:5634-5640.
25. Salih D.A., Mohan S., Kasukawa Y., Tripathi G., Lovett F.A., Anderson N.F., Carter E.J., Wergedal J.E., Baylink D.J., Pell J.M. Insulin-like growth factor-binding protein-5 induces a gender-related decrease in bone mineral density in transgenic mice. Endocrinology 2005, 146:931-940.
26. Schneider M.R., Lahm H., Wu M., Hoeflich A., Wolf E. Transgenic mouse models for studying the functions of insulin-like growth factor-binding proteins. FASEB J. 2000, 14:629-640.
27. Sheng M.H., Baylink D.J., Beamer W.G., Donahue L.R., Lau K.H., Wergedal J.E. Regulation of bone volume is different in the metaphyses of the femur and vertebra of C3H/HeJ and C57BL/6J mice. Bone 2002, 30:486-491.
28. Sheng M.H., Lau K.H., Beamer W.G., Baylink D.J., Wergedal J.E. In vivo and in vitro evidence that the high osteoblastic activity in C3H/HeJ mice compared to C57BL/6J mice is intrinsic to bone cells. Bone 2004, 35:711-719.
29. Sivanandam A.S., Mohan S., Kapur S., Kita H., Lau K.H., Bagi G., Baylink D.J., Qin X. Covalent interaction between proform of eosinophil major basic protein (proMBP) and pregnancy-associated plasma protein-A (PAPP-A) is a cell-mediated event and required for proMBP inhibition of the catalytic activity of PAPP-A. Arch. Biochem. Biophys. 2004, 423:343-350.
30. Stabnov L., Kasukawa Y., Guo R., Amaar Y., Wergedal J.E., Baylink D.J., Mohan S. Effect of insulin-like growth factor-1 (IGF-1) plus alendronate on bone density during puberty in IGF-1-deficient MIDI mice. Bone 2002, 30:909-916.
31. Tanner S.J., Hefferan T.E., Rosen C.J., Conover C.A. Impact of pregnancy-associated plasma protein-a deletion on the adult murine skeleton. J. Bone Miner. Res. 2007.
32. Zhang M., Faugere M.C., Malluche H., Rosen C.J., Chernausek S.D., Clemens T.L. Paracrine overexpression of IGFBP-4 in osteoblasts of transgenic mice decreases bone turnover and causes global growth retardation. J. Bone Miner. Res. 2003, 18:836-843.
33. Zhang M., Smith E.P., Kuroda H., Banach W., Chernausek S.D., Fagin J.A. Targeted expression of a protease-resistant IGFBP-4 mutant in smooth muscle of transgenic mice results in IGFBP-4 stabilization and smooth muscle hypotrophy. J. Biol. Chem. 2002, 277:21285-21290.